Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
about
Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic AgentsNanodiamond-enhanced MRI via in situ hyperpolarizationA novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer.The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches.Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells.Brain-Derived Neurotrophic Factor Loaded PS80 PBCA Nanocarrier for In Vitro Neural Differentiation of Mouse Induced Pluripotent Stem Cells.Current progress on microRNAs-based therapeutics in neurodegenerative diseases.Novel biodegradable nanocarriers for enhanced drug delivery.Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.Brain-Targeted Polymers for Gene Delivery in the Treatment of Brain Diseases.Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator.Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchymaBiogenic synthesis of Marsilea quadrifolia gold nanoparticles: a study of improved glucose utilization efficiency on 3T3-L1 adipocytes.Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease.Rebalancing β-Amyloid-Induced Decrease of ATP Level by Amorphous Nano/Micro Polyphosphate: Suppression of the Neurotoxic Effect of Amyloid β-Protein Fragment 25-35.Anti-Inflammatory Strategy for M2 Microglial Polarization Using Retinoic Acid-Loaded Nanoparticles.PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice.Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.Facile development of nanocomplex-in-nanoparticles for enhanced loading and selective delivery of doxorubicin to brain.Vibrating droplet generation to assemble zwitterion-coated gold-graphene oxide stealth nanovesicles for effective pancreatic cancer chemo-phototherapy.Synthesis of Biocompatible Titanate Nanofibers for Effective Delivery of Neuroprotective Agents.Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.Recent advances in nanomedicine and survivin targeting in brain cancers.Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.Nanoparticle-Based Therapeutics for Brain Injury.Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease.Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.GLUT1 -mediated venlafaxine-thiamine disulfide system-glucose conjugates with "lock-in" function for central nervous system delivery.Peptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic Approach.Enhanced Uptake of Fe₃O₄ Nanoparticles by Intestinal Epithelial Cells in a State of Inflammation.A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin.Getting Drugs Across Biological Barriers.Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles.ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood-brain barrier.Prevention of Synaptic Alterations and Neurotoxic Effects of PAMAM Dendrimers by Surface Functionalization.Current Strategies for Brain Drug Delivery.Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - An illustration with firsthand examples.
P2860
Q28079607-EAD97F45-8FCD-4EFB-ADD0-69750CBFA402Q33629314-0E81800E-3EC5-4146-96FA-1334AF8664E6Q36411071-FFFDE6E4-E7BC-4FA2-A288-1E9FCE1C1F87Q37715304-6C6F8E5F-51A6-4608-9D2F-B01CA3B206C0Q38693583-9FD1C471-FD9E-4DED-B144-FD2C021EDCE8Q38710968-025DFB3A-261E-486B-8C22-E8FED8C7A9F9Q38791303-373D44D4-6B09-42F4-90CB-93C1745A686CQ39005331-E5BCA09F-4969-4CCC-BC05-C52959B17E57Q39031301-21FCBF74-F89D-442C-AFA2-372BE587CE8FQ39154878-85735E69-5C56-46FF-A428-964B57614AD4Q39233422-A4BCD793-9DA1-456B-AA32-6D48970E48DDQ41042662-0C7DFA64-FC2F-416A-ADAF-7CA03E5CDEA8Q41607221-8188E0FD-1E7B-4556-9385-067C106A3A23Q42801715-51C05849-F098-4B54-8FEE-03E1F04CFBD6Q43213548-191AC2CE-D9DB-4A9D-9559-812C147CCD92Q43227037-A5C6F32D-3668-45DC-89CC-07C71FA1F7F5Q43375825-741A625B-877A-4926-B7FC-6A98183D7840Q43980757-F16ED7AC-8899-4870-975E-F97A98FAB015Q44933611-0518E16A-602B-427F-883A-35A38255AF00Q45871459-39E84A6F-F44D-4CA5-9D81-68CB4CCF7561Q46251798-00BDE0C5-EDE9-4A31-A4B7-C71B8925B7F4Q46555341-9E6DABDC-201D-484B-A2C1-28050B9923CFQ47195305-FF6D1F2B-E470-4182-9251-6B964192D5E8Q47266532-10ED2689-759E-49FF-BF23-48031652827BQ47351358-CB2A2486-2185-46FC-9050-4A1BEB03C37AQ47378913-05F79C9C-DFE5-452E-9676-33B0A9DD96A5Q47433079-50678E9E-6547-43F4-9AFA-A08E554EFEA6Q47442352-424D4F18-7BD6-4D7D-8827-6C5FD2530F93Q47712262-1DD4D624-B72B-456B-933E-26897A46CF33Q47724056-7952F9C8-EF39-4B4F-93E5-C7100A28D859Q47730436-321043CD-1CCA-4B5C-977F-E5851735627EQ47933170-A8FED519-4DAF-4117-9BFE-E11012428322Q48021805-3C269085-47BE-4CB0-A255-CFD04D012415Q48185664-CB5676EC-73AD-41DC-A5FC-1A17BF1C130AQ48331228-B183136A-173E-4447-9288-974F6DA4458BQ48384614-C0D5C930-48E0-4E55-BD03-E556EC5C4859Q49421787-BC4B38FB-5A10-4F55-B323-F362C8B611EDQ49520196-E74BE358-9635-4F26-86D5-3A4A037DA918Q51761532-26C46310-D52B-4B58-84C8-A4EFD7CAA6B6Q52561274-83534609-7CA3-48AE-BAC0-9C6404FD3F33
P2860
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@ast
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@en
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@nl
type
label
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@ast
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@en
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@nl
prefLabel
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@ast
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@en
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@nl
P50
P921
P1476
Nanoparticle-mediated brain dr ...... eat neurodegenerative diseases
@en
P356
10.1016/J.JCONREL.2016.05.044
P407
P577
2016-08-10T00:00:00Z